Tenaya Therapeutics, Inc. Common Stock

$0.7999
USD
Last updated on --.
24h volume3.07M
24h highest0.82900 USD
24h lowest0.78400 USD
24h Price movement+2.29%

TNYA recent prices

24 Hours
+2.29%+$0.0179
30 days
+17.51%+$0.121
60 days
+30.97%+$0.192
90 days
+44.54%+$0.2502

Key data

Previous close0.78200 USD
Market cap175.36M USD
Volume3.07M
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-0.38000 USD
Net income (FY)-83.01M USD
Revenue (FY)225.00K USD
Last report dateMay 6, 2026

About Tenaya Therapeutics, Inc. Common Stock

BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
HeadquartersSOUTH SAN FRANCISCO
Employees (FY)70.00
Revenue per employee (FY)3.21K USD
Net income per employee (FY)-1.19M USD
Listed onNasdaq
Official website

TNYA conversion tables

TNYATNYA
USDUSD
0.5 TNYA0.39995 USD
1 TNYA0.7999 USD
5 TNYA3.999 USD
10 TNYA7.999 USD
USDUSD
TNYATNYA
0.5 USD0.62508 TNYA
1 USD1.250 TNYA
5 USD6.250 TNYA
10 USD12.5 TNYA

FAQ

TNYA is trading at $0.7999, +2.29% over the last 24 hours. Track live moves on the price chart at the top of this page.
The TNYA stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. TNYA is currently trading at $0.7999, +2.29% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on TNYA price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. TNYA's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from TNYA; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against TNYA's historical range and other companies in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
Tenaya Therapeutics, Inc. Common Stock's market cap is currently 175.36M USD. Market cap is calculated as stock price × total shares outstanding.

Disclaimer

The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.

OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume3.07M
24h highest0.82900 USD
24h lowest0.78400 USD
24h Price movement+2.29%
TNYATNYA
USDUSD
Start trade with TNYA Perpetual